GLP1R and kidney disorder: On the other hand, a clinical meta-analysis showed that GLP-1RA did not possess specific effects on the retarding of DR [10], apart from other diabetic complications, such as cardiovascular disease [9] or nephropathy [25], which did not support the protective action due to direct GLP-1R activation in the experimental study.